Martinsried, Germany – KINAXO Biotechnologies GmbH announced today that it has entered into a collaboration with AstraZeneca. Under the terms of the agreement, KINAXO will

Biogen Idec (NASDAQ: BIIB) and Neurimmune Holding AG today announced that Biogen Idec has acquired a subsidiary of Neurimmune, which includes the world-wide rights to

Effective September 28th, 2010, Hamburg based HELM AG has purchased a 30% shareholding in Amarin Technologies S.A. a privately owned pharmaceutical development

VaxGen, Inc. , a biopharmaceutical company, and diaDexus, Inc., a privately held diagnostics company

Life Technologies Corporation, a provider of innovative life science solutions, announced today that it has

During an official visit of the Translational Genomics Research Institute (TGen) by H.R.H. Prince Guillaume,

Ambry Genetics and RainDance Technologies today jointly announced at the Annual CHI Next Generation

November 09 – Today, TNO, a Dutch contract research organization, and Seventh Wave, an American organization for contract research and consultancy, announce that the companies have

November 9 – QIAGEN N.V. (QGEN) today announced that it has signed a definite agreement to acquire SABiosciences Corporation, a privately-held developer and manufacturer of disease- and pathway-focused PCR assay

October 15 – KINAXO Biotechnologies GmbH and Bayer Vital GmbH announced today that they will enter into collaboration. KINAXO will apply its quantitative phosphoproteomics technology